Liraglutide exhibits anti-inflammatory activity through the activation of the PKA/CREB pathway
Open accessThe DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.
Abstract
Qihong Que and colleagues found that liraglutide exhibited anti-inflammatory activity through the activation of the PKA/CREB pathway in an OA rat model. We believe there was a flaw in this research. In their first experiment, the sacrifice time of the 10 rats in the control group has not been stated. And when the rats in the OA-1, OA-5, OA-10, OA-20 and OA-28 groups were sacrificed, they were in different weeks of age. If the rats in the control group were compared to the rats in the OA-1, OA-5, OA-10, OA-20 and OA-28 groups respectively, the results may be biased due to differences in the week age of the rats. We believe that addressing this issue could further increase the value of their study.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
The source backs part of the claim, not all of it — or backs it for a different population, condition or comparison.
In the citing paper
“By reducing macrophage-mediated inflammatory responses, GLP-1RAs have the potential to alleviate symptoms of OA, including pain and joint stiffness.281,309”
From Glucagon-like peptide-1 receptor: mechanisms and advances in therapy (2024) · cites this paper as [309]
Experimental — accuracy not yet measured
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Que, Q., Guo, X., Zhan, L., Chen, S., Zhang, Z., Ni, X., Ye, B., & Wan, S. (2019) · Journal of Inflammation · doi:10.1186/s12950-019-0218-y · Cited by 90
Cited by
Glucagon-like peptide-1 receptor: mechanisms and advances in therapy
Zheng, Z., Zong, Y., Ma, Y., Tian, Y., Pang, Y., Zhang, C., & Gao, J. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01931-z · Cited by 1,036
Tian, S., Zhou, S., Wu, W., Lin, Y., Wang, T., Sun, H., Aniwan, A., Li, Y., Wang, C., Li, X., et al. (2024) · Advanced Science · doi:10.1002/advs.202409781 · Cited by 77
Sun, B., Jia, X., Yang, F., Ren, G., & Wu, X. (2020) · Neuroscience Research · doi:10.1016/j.neures.2020.05.003 · Cited by 27
Poupon-Bejuit, L., Hughes, M. P., Liu, W., Geard, A. F., Faour-Slika, N., Whaler, S. M., Massaro, G., & Rahim, A. A. (2022) · Scientific Reports · doi:10.1038/s41598-022-17338-1 · Cited by 20
Wang, C., & Lizhe, Q. (2022) · Bioengineered · doi:10.1080/21655979.2022.2036899 · Cited by 18
Metadata
- Authors
- Wang, L., Feng, L., & Zhang, J.
- Affiliations
- Second Hospital of Tangshan (CN)
- North China University of Science and Technology Affiliated Hospital (CN)
- Corresponding author
- Wang, Li
- Venue
- Journal of Inflammation
- Published
- 2019-10-11
- Volume
- 16
- Issue
- 1
- Pages
- 21-21
- ISSN
- 1476-9255 (ISSN-L)
- PMC
- PMC6787966
- OpenAlex
- W2979425222
- Cited by
- 8
- References
- 1
- Citations by year
- 2024: 3 · 2023: 1 · 2022: 3 · 2020: 1
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Licence
- cc-by
- creativecommons.org/licenses/by/4.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor)
- Locations
- Journal of Inflammation (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Topics
- Health Sciences › Medicine › Rheumatology › Osteoarthritis Treatment and Mechanisms
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cell Biology › Proteoglycans and glycosaminoglycans research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Bone Metabolism and Diseases
- Keywords
- liraglutide, anti-inflammatory activity, osteoarthritis, rat model, GLP-1 receptor agonists
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Liraglutide exhibits anti-inflammatory activity through the activation of the PKA/CREB pathway. https://app.cochat.ai/papers/10.1186/s12950-019-0225-z
- The paper
- Wang, L., Feng, L., & Zhang, J. (2019). Liraglutide exhibits anti-inflammatory activity through the activation of the PKA/CREB pathway. Journal of Inflammation. https://doi.org/10.1186/s12950-019-0225-z
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.